Placental programming of metabolic diseases: molecular pathways from maternal pregnancy complications to offspring metabolic risk
- 1Department of Medical Genetics and Prenatal Diagnosis, Hainan Women and Children’s Medical Center
Abstract
Introduction: The placenta is increasingly recognized as a dynamic regulatory organ that translates both maternal and paternal physiological and pathological states into developmental signals into developmental signals shaping offspring health across the lifespan. In the context of maternal metabolic and obstetric complications, placental function extends far beyond the regulation of fetal growth, influencing key aspects of development including endocrine set points, nutrient allocation, inflammatory responses, vascular adaptation, and molecular programming across fetal organs.
Results: This review examines how maternal conditions —such as obesity, gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy, undernutrition, micronutrient imbalance, and maternal inflammatory stress —induce structural, endocrine, vascular, metabolic, and epigenetic alterations in the placenta. We further explore how these changes disrupt critical molecular pathways, including nutrient sensing and transport, oxidative stress responses, mitochondrial function, angiogenesis and glucocorticoid signaling, immune regulation, and gene expression. A central focus is the convergence of placental mechanisms across diverse maternal disorders, leading to shared offspring phenotypes such as insulin resistance, increased adiposity, dyslipidemia, impaired glucose regulation, altered appetite control, and elevated risk of cardiometabolic disease later in life.
Conclusion: Additionally, we address sex-specific placental adaptations, fetal tissue vulnerability, and the translational potential of placental biomarkers and omics-based approaches supported by mechanistic experimental models. By positioning the placenta as the primary biological interface linking maternal complications to offspring susceptibility to endocrine and complex metabolic diseases, this review provides an integrated framework for understanding developmental programming in metabolic health.
Related
- First trimester, one-tube screening for pregnancy complications via placental biomarkers
- Alcohol-induced placental vasculopathy reprograms the placental-fetal cardiovascular axis: angiogenic mechanisms linking maternal alcohol exposure to developmental cardiovascular programming
- Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
- The Least Understood Placental Galectins: Galectin-14 and Galectin-16 in Human Pregnancy and Placental Biology
- Placental Growth Factor Trajectories During Pregnancy and Child ADHD
BibTeX
@article{zhou2026placental,
title = {{Placental programming of metabolic diseases: molecular pathways from maternal pregnancy complications to offspring metabolic risk}},
author = {Duo Zhou},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1860825},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1860825/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Placental programming of metabolic diseases: molecular pathways from maternal pregnancy complications to offspring metabolic risk
AU - Duo Zhou
PY - 2026
DA - 2026/10/26
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1860825
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1860825/full
AB - Introduction: The placenta is increasingly recognized as a dynamic regulatory organ that translates both maternal and paternal physiological and pathological states into developmental signals into developmental signals shaping offspring health across the lifespan. In the context of maternal metabolic and obstetric complications, placental function extends far beyond the regulation of fetal growth, influencing key aspects of development including endocrine set points, nutrient allocation, inflammatory responses, vascular adaptation, and molecular programming across fetal organs. Results: This review examines how maternal conditions —such as obesity, gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy, undernutrition, micronutrient imbalance, and maternal inflammatory stress —induce structural, endocrine, vascular, metabolic, and epigenetic alterations in the placenta. We further explore how these changes disrupt critical molecular pathways, including nutrient sensing and transport, oxidative stress responses, mitochondrial function, angiogenesis and glucocorticoid signaling, immune regulation, and gene expression. A central focus is the convergence of placental mechanisms across diverse maternal disorders, leading to shared offspring phenotypes such as insulin resistance, increased adiposity, dyslipidemia, impaired glucose regulation, altered appetite control, and elevated risk of cardiometabolic disease later in life. Conclusion: Additionally, we address sex-specific placental adaptations, fetal tissue vulnerability, and the translational potential of placental biomarkers and omics-based approaches supported by mechanistic experimental models. By positioning the placenta as the primary biological interface linking maternal complications to offspring susceptibility to endocrine and complex metabolic diseases, this review provides an integrated framework for understanding developmental programming in metabolic health.
SN - 1664-2392
ER -